Commercial Co-Pay Program for ZARXIO
The Sandoz One Source Commercial Co-Pay Program for ZARXIO was created to support eligible,* commercially insured patients with their out-of-pocket co-pay costs for ZARXIO.
One enrollment form
Use the Sandoz One Source enrollment form to request patient-specific Reimbursement Services and to enroll patients in the Commercial Co-Pay Program. The Novartis Patient Assistance Foundation will also use this form to assess patients for the Patient Assistance Program (PAP) when applicable.
If you have additional questions, call 1-844-SANDOZ1 (1-844-726-3691) and select option 2.
Maximum benefit of $10,000 annually. Prescription must be for an approved indication. This program is not health insurance. This program is for insured patients only; cash-paying or uninsured patients are not eligible. Patients are not eligible if prescriptions are paid, in whole or in part, by any state or federally funded programs, including but not limited to Medicare (including Part D, even in the coverage gap) or Medicaid, Medigap, VA, DOD, or TriCare, or private indemnity plans that do not cover prescription drugs, or HMO insurance plans that reimburse the patient for the entire cost of their prescription drugs, or where prohibited by law. Patients can participate for a maximum of 12 months. Co-Pay Program may not be combined with any other rebate, coupon, or offer. Sandoz reserves the right to rescind, revoke, or amend this offer without further notice.
Patient support services
Sandoz One Source provides comprehensive patient support services designed to help simplify and support patient access. Sandoz One Source offers a variety of customized services for patients prescribed ZARXIO, including:
- Comprehensive insurance verifications
- Prior authorization information
- Billing and coding information
- Claims tracking information
- Denials/Appeals information
- General payer policy research
Sandoz One Source is available to assist patients with:
- Information on external resources and support
- Understanding Sandoz One Source Commercial Co-Pay Program eligibility
This website provides general information and is not intended to provide reimbursement or legal advice. Furthermore, it is not intended to increase or maximize payment by any payer. Because laws, regulations, and coverage policies are complex and updated frequently, you should check with your local Medicare carrier and payers often or go to www.cms.gov.
Nothing in the information provided shall be construed as a guarantee of Sandoz regarding levels of reimbursement, payment, or charge that reimbursement will be received. The ultimate responsibility for obtaining reimbursement lies with the physician, provider, or patient. Please consult with your counsel or reimbursement specialist for any practice-specific reimbursement or billing questions.
ZARXIO and Sandoz One Source are registered trademarks of Novartis AG.